Results 101 to 110 of about 100,933 (268)

A Retrospective Study on the Impact of Primary Aldosteronism in Pregnancy (H.A.P.P.I. Study Group)

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objective Primary aldosteronism (PA) is a common cause of hypertension in young women. However, there is a paucity of data regarding its impact during pregnancy. The primary objective of this study was to describe the occurrence of hypertensive disorders of pregnancy (HDP) in PA.
Diana Oprea   +7 more
wiley   +1 more source

The Effects of GnRH and hCG Administration on Pregnancy Rate in Postpartum Dairy Cows

open access: bronze, 2022
Emre KARSAVURANOĞLU   +2 more
openalex   +2 more sources

Gliotransmission by Prostaglandin E2: A Prerequisite for GnRH Neuronal Function? [PDF]

open access: gold, 2011
Jérôme Clasadonte   +3 more
openalex   +1 more source

Conventional and new proposals of GnRH therapy for ovarian, breast, and prostatic cancers [PDF]

open access: gold, 2023
Maritza P. Garrido   +4 more
openalex   +1 more source

Impact of Growth Hormone Treatment in Children From an Extended Family With ACAN‐Related Short Stature

open access: yesClinical Genetics, EarlyView.
This study evaluated growth hormone (GH) therapy in children from an extended family with genetically confirmed ACAN‐related short stature. While GH treatment improved growth velocity, the response varied among individuals, and its long‐term impact on final adult height remains to be determined.
Einat Shalev‐Goldman   +5 more
wiley   +1 more source

Natural cycle IVF/ICSI with late follicular phase GnRH-antagonist administration: results according to subfertility diagnosis [PDF]

open access: bronze, 2002
M.J. Pelinck   +5 more
openalex   +1 more source

Pharmacological intervention: Challenges and promising outcomes for fat loss and preservation of lean body mass in the treatment of overweight and type 2 diabetes

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Treatment with GLP‐1 receptor agonists (GLP‐1 RAs) is effective in reducing body weight in individuals with overweight and type 2 diabetes (T2D). However, measurements indicate that a considerable portion of the weight loss derives from fat‐free mass (FFM), including skeletal muscle, which may compromise metabolic health and physical function.
Viktor Aimelet, Jens Juul Holst
wiley   +1 more source

New‐onset prediabetes/diabetes worsens overall survival in patients with cancer: A real‐world retrospective cohort study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Cancer diagnosis may increase the risk of developing prediabetes/diabetes and subsequently worsen survival in cancer patients. However, it is unclear whether this association is influenced by the timing of hyperglycemia onset or the use of antihyperglycemic medications.
Maci Winn   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy